John Lin
@johnlin08.bsky.social
📤 198
📥 132
📝 0
Medical oncologist and health services researcher. Assistant Professor, MD Anderson Cancer Center
reposted by
John Lin
7 months ago
According to MedPAC, details of the Part D redesign mean that some enrollees will hit their $2,000 OOP maximum much faster than I realized. In one example, they show how one could hit the max with just $470 in spending.
1
1
1
reposted by
John Lin
Matthew Rae
8 months ago
If you are downloading data right now - I recommend
asdfree.com
. Anthony Damico has R scripts to download ~50 public surveys, create the survey design and save them locally. If you are an R user this will things go much faster!
loading . . .
Analyze Survey Data for Free
Analyze Survey Data for Free
https://asdfree.com/
0
8
10
reposted by
John Lin
Stacie Dusetzina
9 months ago
HHS announces the next 15 drugs to negotiate under Part D! Great to see this progress. Quite a few cancer treatments, which will mean more savings potential than in the first year's drug list (cancer drugs get limited or no rebates today). Good news for taxpayers and Medicare spending!
loading . . .
https://www.hhs.gov/about/news/2025/01/17/hhs-announces-15-additional-drugs-selected-medicare-drug-price-negotiations-continued-effort-lower-prescription-drug-costs-seniors.html
3
81
25
reposted by
John Lin
Ben Rome
9 months ago
📰 15 more drugs up for Medicare price negotiation this year. Including the blockbuster diabetes/obesity drug semaglutide!! 💊🩺📈🧪
www.cms.gov/newsroom/pre...
loading . . .
HHS Announces 15 Additional Drugs Selected for Medicare Drug Price Negotiations in Continued Effort to Lower Prescription Drug Costs for Seniors | CMS
Medicare has selected 15 more drugs to negotiate directly with participating drug companies. Building on the success of the first round of negotiations, the aim is to lower prices for some more of the...
https://www.cms.gov/newsroom/press-releases/hhs-announces-15-additional-drugs-selected-medicare-drug-price-negotiations-continued-effort-lower
0
6
4
reposted by
John Lin
Aaron Schwartz
9 months ago
It was a pleasure to write this piece for Health Affairs on risk adjustment in Medicare. Risk adjustment modifies payments to health plans or ACOs based on patient/beneficiary characteristics. Here's a very brief summary of my thoughts🧵
www.healthaffairs.org/doi/abs/10.1...
2
27
16
reposted by
John Lin
Larry Levitt
9 months ago
Starting today, Medicare beneficiaries will have their annual out-of-pocket drug costs capped at $2,000 as a result of the Inflation Reduction Act.
www.kff.org/medicare/iss...
loading . . .
Millions of People with Medicare Will Benefit from the New Out-of-Pocket Drug Spending Cap Over Time | KFF
In 2025, Medicare beneficiaries will pay no more than $2,000 out of pocket for prescription drugs covered under Part D, Medicare’s outpatient drug benefit, due to a provision in the Inflation Reductio...
https://www.kff.org/medicare/issue-brief/millions-of-people-with-medicare-will-benefit-from-the-new-out-of-pocket-drug-spending-cap-over-time/
48
1022
480
reposted by
John Lin
Pedro Sant’Anna
10 months ago
Here are the first five sets of slides: 01 Introduction:
psantanna.com/DiD/01_Intro...
02 Classical 2x2 setup:
psantanna.com/DiD/02_two_b...
03 Clustering issues:
psantanna.com/DiD/03_Clust...
04 Functional form:
psantanna.com/DiD/04_Funct...
05 Covariates:
psantanna.com/DiD/05_Covar...
add a skeleton here at some point
52
737
196
you reached the end!!
feeds!
log in